DEMECAN has raised €7M in Series A round

The Berlin startup DEMECAN has closed a Series A financing round of 7 million euros, co-led by btov Partner’s Private Investor Network and a FMCG Family Office.

DEMECAN is the only company allowed to produce medical cannabis in Germany. They are also acting as an importer and wholesaler and can therefor cover the entire value chain.

Read more about it at TechCrunch or at Wirtschaftswoche Gründer.